GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Days Sales Outstanding

DT&CRO Co (XKRX:383930) Days Sales Outstanding : 38.23 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Days Sales Outstanding?

DT&CRO Co's average Accounts Receivable for the three months ended in Mar. 2024 was ₩2,756 Mil. DT&CRO Co's Revenue for the three months ended in Mar. 2024 was ₩6,579 Mil. Hence, DT&CRO Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 38.23.

The historical rank and industry rank for DT&CRO Co's Days Sales Outstanding or its related term are showing as below:

XKRX:383930' s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.42   Med: 39.89   Max: 72.48
Current: 44.9

During the past 4 years, DT&CRO Co's highest Days Sales Outstanding was 72.48. The lowest was 25.42. And the median was 39.89.

XKRX:383930's Days Sales Outstanding is ranked better than
73.93% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs XKRX:383930: 44.90

DT&CRO Co's Days Sales Outstanding increased from Mar. 2023 (26.21) to Mar. 2024 (38.23).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


DT&CRO Co Days Sales Outstanding Historical Data

The historical data trend for DT&CRO Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Days Sales Outstanding Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
72.48 37.10 25.42 42.68

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.21 25.54 35.49 342.44 38.23

Competitive Comparison of DT&CRO Co's Days Sales Outstanding

For the Biotechnology subindustry, DT&CRO Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DT&CRO Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DT&CRO Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where DT&CRO Co's Days Sales Outstanding falls into.



DT&CRO Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

DT&CRO Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (3461.512 + 2756.161) / 2 ) / 26586.277*365
=3108.8365 / 26586.277*365
=42.68

DT&CRO Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (2756.161 + 0) / 1 ) / 6579.29*365 / 4
=2756.161 / 6579.29*365 / 4
=38.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DT&CRO Co  (XKRX:383930) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


DT&CRO Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


DT&CRO Co (XKRX:383930) Business Description

Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines